arctigenin has been researched along with Colitis-Associated Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dai, Y; Lv, C; Miao, Y; Qiao, S; Sun, D; Tao, Y; Wei, Z; Xia, Y; Yun, X; Zhang, W; Zhu, Y | 1 |
1 other study(ies) available for arctigenin and Colitis-Associated Cancer
Article | Year |
---|---|
Arctigenin disrupts NLRP3 inflammasome assembly in colonic macrophages via downregulating fatty acid oxidation to prevent colitis-associated cancer.
Topics: Animals; Carnitine O-Palmitoyltransferase; Colitis-Associated Neoplasms; Colon; Down-Regulation; Fatty Acids; Furans; Inflammasomes; Interleukin-1beta; Lignans; Macrophages; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidation-Reduction | 2020 |